Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Feasibility of Liver Biomarkers as Prognostic Markers in Decompensated Alcoholic Liver Disease

NCT01701687 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT01701687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01701687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Feasibility of Liver Biomarkers as Prognostic Markers in Decompensated Alcoholic Liver Disease
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Completed
Start date
September 30, 2012
Completion date
July 31, 2015
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholic liver diseases, decompensated cirrhosis